Objective: To determine a cut-o value of Chest CT severity score (CT-SS) in order to discriminate between the clinical types of COVID-19 pneumonia. Study Design: Observational study. Place and Duration of Study: Department of Radiology, Shifa International Hospital, from 1st March to June 30th, 2020. Methodology: One hundred and three consecutive patients RT PCR positive for COVID-19 were included. Two consultant radiologists, with experience of 7 to 10 years in body imaging, evaluated their HRCT studies in consensus and calculated the CT severity score. A scoring of all 20 individual regions in each lung were assigned by the radiologists attributing a score of 0, 1 or 2 to each region, if parenchymal opaci cation was none, less than 50%, or 50% or more, respectively. The CT severity score was a summation of scores of all 20 regions of both lungs combined with a range of 0 to 40 points. The scores were compared for clinically mild and severe disease. Results: Signi cant di erences were noted regarding the scoring of lung opacity in mild and severe groups in each lung segment, p <0.05. The most signi cantly involved segments were right lower lobe s medial and lateral basal segment, left upper lobe s superior lingular segment and left lower lobe s medial basal and lateral basal segments. To discriminate mild versus severe disease, CT-SS threshold value turned out to be 19.5 Conclusion: CTSS may be of value for a prompt and objective means of assessing the degree of severity and disease burden in lungs.